TY - JOUR T1 - Sulfation of <em>O</em>-glycans on mucin-type proteins from serous ovarian epithelial tumors JF - medRxiv DO - 10.1101/2021.07.05.21259706 SP - 2021.07.05.21259706 AU - Kristina A. Thomsson AU - Varvara Vitiazeva AU - Constantina Mateoiu AU - Chunsheng Jin AU - Jining Liu AU - Jan Holgersson AU - Birgitta Weijdegard AU - Karin Sundfeldt AU - Niclas G. Karlsson Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/07/06/2021.07.05.21259706.abstract N2 - Despite that sulfated O-linked glycans are abundant on ovarian cancer (OC) glycoproteins, their regulation during cancer development and involvement in cancer pathogenesis remain unexplored. We characterized O-glycans carrying sulfation on galactose residues and compared their expression to defined sulfotransferases regulated during OC development. Desialylated sulfated oligosaccharides were released from acidic glycoproteins in the cyst fluid from one patient with a benign serous cyst and one patient with serous OC. Oligosaccharides characterized by LC-MSn were identified as core 1 and core 2 O-glycans up to the size of decamers, and with 1-4 sulfates linked to GlcNAc residues and to C-3 and/or C-6 of Gal. To study the specificity of the potential ovarian sulfotransferases involved, Gal3ST2 (Gal-3S)-, Gal3ST4 (Gal-3S)-, and CHST1 (Gal-6S)-encoding expression plasmids were transfected individually into CHO cells also expressing the P-selectin glycoprotein ligand-1/mouse immunoglobulin G2b (PSGL-1/mIg G2b) fusion protein and the human core 2 transferase (GCNT1). Characterization of the PSGL-1/mIg G2b O-glycans showed that Gal3ST2 preferentially sulfated Gal on the C-6 branch of core 2 structures and Gal3ST4 preferred Gal on the C-3 branch independently if core-1 or-2. CHST1 sulfated Gal residues on both the C-3 (core 1/2) and C-6 branches of core 2 structures. Using serous ovarian tissue micro array, Gal3ST2 was found to be decreased in tissue classified as malignant compared to tissues classified as benign or borderline, with the lowest expression in poorly differentiated malignant tissue. Neither Gal3ST4 nor CHST1 were differentially expressed in benign, borderline or malignant tissue, and there was no correlation between expression level and differentiation stage. The data displays a complex sulfation pattern of O-glycans on OC glycoproteins and that aggressiveness of the cancer is associated with a decreased expression of the Gal3ST2 transferase.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by grants for (NGK) from the Swedish state under the agreement between the Swedish government and the county council, the ALF-agreement (ALFGBG-722391, NGK and ALFGBG-725381, KS), the Swedish Research Council (621-2013-5895, NGK) and Petrus and Augusta Hedlunds foundation (M-2016-0353). VV was supported from Assar Gabrielssons foundation (FB16-102). The funding agencies were not involved in the conducted research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics Committee at Sahlgrenska University HospitalAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw MS data and Glycoworkbench files which includes fragment ion assignment for ovarian cancer cyst fluid O-glycan analyses are available on glycopost ( https://glycopost.glycosmos.org/) using the project ID: GPST000192. Structures with available MIRAGE information are available at Unicarb-DR (https://unicarb-dr.glycosmos.org/references/453). Raw MS data for analyses of O-glycans from PSGL1/mIg2b co transfected with sulfotransferases Gal3T2, Gal3ST4 and CHST1 and with or without core 2 transferase GCNT1 are available at glycopost using the project IDS: GPST000198 and GPST000199, respectively. Structures with available MIRAGE information are available at Unicarb-DR, reference numbers 456 (core2+CHST1), 457 (core2+Gal3ST2), 458 (core2+Gal3ST4), 459(core1+Gal3ST4) and 460(core1+CHST1). https://glycopost.glycosmos.org/ https://unicarb-dr.glycosmos.org/references/453 https://unicarb-dr.glycosmos.org/references/456 https://unicarb-dr.glycosmos.org/references/457 https://unicarb-dr.glycosmos.org/references/458 https://unicarb-dr.glycosmos.org/references/459 OCovarian cancer;HGSChigh grade serous carcinoma,LGSClow-grade serous carcinoma;Tn antigenGalNAc-á-Threonine/Serine;T antigenGalâ1-3GalNAc-Threonine/Serine;sLeasialyl Lewis a;sLexsialyl Lewis x;Hexhexose;HexNAcNacetylhexosamine;LC-MSliquid chromatography-mass spectrometry;CHO cellschinese hamster ovary cells;TMAtissue micro array ER -